JeromeCanadyMDFACS

General Surgery • Washington, DC

Hepatobiliary Surgery, Surgical Oncology (Other than Breast), Transplantation, Trauma Surgery & Surgical Critical Care

Canady Surgical Group, P.C Attending Surgeon, Founding Partner

Join to view full profile

Dr. Canady is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Canady's full profile

Already have an account?

Office
106 Irving St NW
Ste 406
Washington, DC 20010
Phone+1 202-877-0531

Fax+1 301-270-0849

Education & Training

Sheba Medical CenterSurgical Onoclogy, Peritoneal Surface Malignancy, Cytoreductive Abdominal Surgery, Complex Abdominal Oncological Surgery, Certificate, 2019 - 2020
University of Pittsburgh School of MedicineClinical Transplant Senior Fellow, Multivisceral & Intestinal Transplantation (Adult & Children), Pediatric Transplantation, American Society of Transplant surgeons (Certified) University of Pittsburgh School of Medicine and Medical Center,Children's Hospital of Pittsburgh, 2002 - 2002
Humboldt University zu Berlin (Virkow Klinikum)Advanced Multi-Organ Transplantation, Complex Abdominal Oncological Surgery, Hepatobiliary & Pancreatic Surgery (Malignant & Benign Diseases)), Visceral and Organ Transplantation, Certificate, 2001 - 2002
Yale School of MedicineAbdominal Transplant Surgery (Liver, Kidney, Pancreas), Organ Transplantation, The American Society of Transplant Surgeons (Certified) Yale University School of Medicine, Yale New-Haven Hospital, 1999 - 2001
Yale School of MedicinePostodoctoral Fellow, Immunology, 1999 - 2001
UPMC Medical Education (Pittsburgh)Residency, Surgery, 1990 - 1993
Rutgers Health/New Jersey Medical SchoolResidency, Surgery, 1989 - 1990
Meharry Medical College School of MedicineResidency, Surgery, 1985 - 1988
University of Illinois College of Medicine at ChicagoResidency, Surgery, 1984 - 1985
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1982 - 1984
Howard UniversityInternship, Internal Medicine, 1981 - 1982
Lewis Katz School of Medicine at Temple UniversityClass of 1981
Villanova UniversityBachelor Arts, German, Russian, 1972 - 1976

Certifications & Licensure

FL State Medical License 2008 - 2027
MD State Medical License 2015 - 2026
VA State Medical License 1983 - 2026
VI State Medical License 2020 - 2026
DC State Medical License 1983 - 2024
IL State Medical License 1984 - 2017
PA State Medical License 1983 - 2010
NJ State Medical License 1989 - 1991
TN State Medical License 1986 - 1989
American Board of Surgery Surgery
Join now to see all

Clinical Trials

Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites Start of enrollment: 2019 Jul 30
Active, not recruiting
Not Applicable

Publications & Presentations

PubMed

15 citations
The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer.
Jerome Canady, Saravana R K Murthy, Taisen Zhuang, Steven Gitelis, Aviram Nissan
Cancers. 2023-07-20
3 citations
Canady Cold Helios Plasma Reduces Soft Tissue Sarcoma Viability by Inhibiting Proliferation, Disrupting Cell Cycle, and Inducing Apoptosis: A Preliminary Report.
Lawan Ly, Xiaoqian Cheng, Saravana R K Murthy, Olivia Z Jones, Taisen Zhuang
Molecules. 2022-06-29
6 citations
BCL2A1 regulates Canady Helios Cold Plasma-induced cell death in triple-negative breast cancer.
Saravana R K Murthy, Xiaoqian Cheng, Taisen Zhuang, Lawan Ly, Olivia Jones
Scientific Reports. 2022-03-08

Press Mentions

JCRI - ABTS and USMI to Present a Two-Year Follow-up of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at Israeli Society of Surgical OncologyMay 12th, 2022
Jerome Canady Research Institute for Advanced Biological and Technological Sciences Discovers Regulatory Gene BCL2A1 for Treatment of Triple-Negative Breast CancerMarch 15th, 2022
USMI to Announce Successful Results of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at the Baird 2021 Global Healthcare ConferenceSeptember 9th, 2021
Join now to see all